“…Its derivatives possess versatile activity, e.g., carbonic anhydrase inhibitors (Supuran et al, 1998), anticancer (Reddy et al, 2004), anti-inflammatory (Li et al, 1995), anti-HIV (Selvam et al, 2001), COX-2 inhibitors (Dannhardt et al, 2002), selective 5-HT receptor antagonist (Bromidge et al, 2002), antitubercular (Kamal et al, 2007) and antifungal (Briganti et al, 1997) etc. Pyridoquinolones were synthesized and evaluated for antimicrobial activity (Lee et al, 1992;Chang, 1994, 1996), in which pyridine ring was fused with quinazoline ring, and generally known as phenanthroline. The structure-activity relationships of fluoroquinolone have been studied in some reviews (Mitscher, 2005;Bhanot et al, 2001); consideration of the above facts and the presence of fused pyrido ring in nalidixic acid urged us to synthesize structurally similar compounds to fluoroquinolone by replacing fluoro group with chloro and hydroxy groups at C-6 possition with fused pyrido ring; the carboxylic acid group was further converted to amides for enhanced antimicrobial activity.…”